Is a C5-7 anterior cervical discectomy and fusion, including the use of bone graft substitutes and spinal fixation devices, medically indicated for a patient with cervical stenosis and spondylosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Medical Necessity Determination for C5-7 Anterior Cervical Discectomy and Fusion

This C5-7 anterior cervical discectomy and fusion (ACDF) with instrumentation, bone grafting, and interbody devices is medically indicated for this patient. The patient meets all established clinical criteria for surgical intervention, and the proposed procedure aligns with evidence-based guidelines for treating multilevel cervical stenosis with radiculomyelopathy.

Clinical Justification

Patient Meets All Surgical Criteria

The patient satisfies every requirement established by neurosurgical guidelines for cervical decompression and fusion 1, 2:

  • Neural compression confirmed on imaging: MRI demonstrates moderate to severe central canal stenosis at C5-6 and severe left foraminal stenosis at C6-7, corresponding directly to clinical symptoms 1

  • Objective neurological deficits present: Patient exhibits motor weakness (frequent dropping of objects from left hand), sensory changes (radiation to bilateral upper extremities, worse on left), and balance impairment indicating myeloradiculopathy 1, 2

  • Failed conservative management: Patient has completed physical therapy, chiropractic care, and pain management over 3 months without improvement, now requiring opioid analgesia 1

  • Progressive functional impairment: Symptoms are worsening despite conservative treatment, with significant impact on activities of daily living 1

  • Appropriate anatomic levels: Two-level disease at C5-7 falls within the optimal range for anterior cervical approach 1, 2

Surgical Approach Selection

ACDF is the recommended technique for this patient's pathology based on multiple factors 1, 2:

  • Compression at disc levels: The pathology is primarily at C5-6 and C6-7 disc spaces, making ACDF the preferred approach over corpectomy 1, 2

  • Two-level disease: ACDF demonstrates 73-74% improvement rates for multilevel cervical stenosis, superior to laminectomy's 50% improvement and without the 29% late deterioration rate seen with posterior-only approaches 1

  • Cervical kyphosis present: CT scan shows cervical kyphosis, which is an indication favoring anterior approach to restore lordosis 1, 2

  • Anterior plating recommended: For two-level ACDF, anterior plate fixation improves fusion rates and reduces pseudarthrosis risk, particularly important given the patient's kyphotic alignment 1

Procedural Components Justification

CPT 22551 and 22552 (Primary and Additional Level Fusion)

Two-level ACDF at C5-6 and C6-7 is appropriate for the documented pathology 1, 3:

  • Multilevel ACDF achieves 96% fusion rates at one year when using interbody devices, even without plating 3

  • Two-level procedures demonstrate comparable outcomes to single-level surgery with proper technique and instrumentation 3, 4

  • The use of anterior plating allows equivalent fusion rates between multilevel ACDF and corpectomy approaches 1

CPT 20930 (Allograft Morsel) and 20936 (Autograft)

Bone graft materials are medically necessary for achieving solid arthrodesis 1:

  • Allograft materials that are 100% bone are considered medically necessary for spinal fusions regardless of implant shape 1

  • Revision surgery data shows 97% fusion rates with allograft when combined with anterior plating, with 86% achieving excellent or good outcomes 1

  • Autograft or allograft supplementation reduces pseudarthrosis risk in multilevel constructs 1

CPT 22845 (Spinal Fixation Device - Anterior Plate)

Anterior cervical plating is indicated for two-level fusion 1:

  • Plating improves arm pain outcomes in two-level disease compared to fusion without instrumentation 1

  • Anterior plate fixation allows equivalent fusion rates between ACDF and corpectomy techniques 1

  • Plating reduces pseudarthrosis and graft-related complications, though these are Class III evidence 1

CPT 22853 x2 (Interbody Biomechanical Devices)

Synthetic interbody cages/spacers are medically necessary for this cervical fusion 3, 4:

  • Interbody fusion devices have load-sharing function and stabilize the spine to increase segmental stiffness, achieving fusion rates of 95-96% even in multilevel disease 3, 4

  • Cages restore cervical lordosis in patients with preoperative loss of lordosis, which applies to this patient with documented kyphosis 3

  • Long-term outcomes at 5-8 years show 80% excellent or good results with titanium cages, with 95% fusion rates 4

Important Clinical Considerations

Progressive Myelopathy Warrants Urgent Intervention

The combination of motor weakness, balance impairment, and worsening symptoms despite conservative care suggests evolving myelopathy 1, 2. Surgical decompression should not be delayed as outcomes are better when symptoms have been present for less than one year 1.

Adjacent Segment Disease Risk is Acceptable

While 36-50% of patients develop radiographic adjacent segment changes after ACDF, only 2-5% require reoperation 5, 4. Fusion to C7 does not increase adjacent segment disease risk at the cervicothoracic junction compared to more cephalad fusions 5.

Avoid Common Pitfalls

  • Do not perform laminectomy alone: Posterior decompression without fusion has a 29% late deterioration rate and should be avoided 1, 2

  • Ensure adequate decompression: Both central canal stenosis at C5-6 and foraminal stenosis at C6-7 must be addressed to resolve bilateral symptoms 1

  • Monitor for pseudarthrosis: Two-level constructs have higher nonunion risk without plating, making anterior instrumentation essential 1

Summary of Medical Necessity

All requested CPT codes are medically indicated for this patient's documented cervical stenosis with myeloradiculopathy. The patient meets established clinical criteria, has failed appropriate conservative management, demonstrates progressive neurological decline, and the proposed two-level ACDF with instrumentation represents the evidence-based standard of care for this pathology 1, 2.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Surgical Approaches for Cervical Myelopathy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

Is anterior cervical discectomy and fusion (ACDF) at C4-C5 and C6-7 medically indicated for a patient with cervical myelopathy and severe spinal stenosis?
Is an anterior cervical discectomy and fusion (ACDF) at C4-5 medically necessary for a patient with cervical spinal stenosis, spondylolisthesis, and cervical spondylosis with myelopathy at C4-5?
Is a C2-C7 anterior cervical discectomy and fusion (ACDF) with pedicle screw, cage, allograft (bone graft), autograft (bone graft), and bone marrow aspirate indicated for a patient with advanced cervical disc degeneration, significant arthritis, and degenerative changes, who has failed nonoperative treatment and experiences severe neck pain and stiffness?
What is the step-by-step procedure for Anterior Cervical Discectomy and Fusion (ACDF) of the C5-C6 interspace for treatment of a Protruded Intervertebral Disc (PIVD)?
Is anterior cervical discectomy and fusion (ACDF) with pedicle screw, cage, allograft (bone graft substitute), and autograft (patient's own bone graft) indicated for a patient with cervical spondylosis and radiculopathy who has not met cervical spinal fusion criteria?
Can Clomiphene (selective estrogen receptor modulator) raise Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) levels in patients taking exogenous Testosterone (hormone replacement therapy)?
What is the recommended management for patients with left bundle branch block (LBBB) at risk of sudden cardiac death?
What does a Prostate-Specific Antigen (PSA) level of 5.2 indicate?
What is the management approach for patients with low lymphocyte count (lymphopenia)?
Can root canal treatment be done in all teeth or are there contraindications?
What is the immediate management for a patient diagnosed with Takotsubo (stress) cardiomyopathy?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.